Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-03-29

Clinical Trial Update: Pharmacokinetics and Safety Studies of Esomeprazole Use in Schizophrenia Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update assessing the pharmacokinetics and safety of esomeprazole in patients with schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Esomeprazole (Esomeprazole)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED